BioPharmSignal logoBioPharmSignal

Biotech News

Intelligent Bio Solutions to Present at the Webull Biotech Webinar on November 12

Intelligent Bio Solutions (INBS)Intelligent Bio SolutionsCompany update

Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that management will present at the Webull Biotech Webinar on Thursday, November 12, 2026.

Related news

INBSIntelligent Bio Solutions2026-09-01 12:30 EST

Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules

INBSIntelligent Bio Solutions2026-08-11 12:30 EST

Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System

FLGTFulgent Genetics, Inc.2026-04-22 20:05 EST

Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting

XGNExagen2026-10-27 13:00 EST

Exagen to Announce Third Quarter Financial Results on November 10, 2026

BDSXBiodesix2026-10-22 10:00 EST

Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026

FLGTFulgent Genetics, Inc.2026-10-15 20:05 EST

Fulgent to Announce Third Quarter 2026 Financial Results on Thursday, November 5, 2026

OSUROraSure Technologies, Inc.2026-10-26 20:05 EST

OraSure to Announce Third Quarter 2026 Financial Results and Host Earnings Call on November 9th

View all latest news

Intelligent Bio Solutions

Fingerprint Drug Screening Company Intelligent Bio Solutions develops rapid, non-invasive drug-testing systems that analyze fingerprint sweat. Its platform is used in workplace and safety-sensitive environments outside the United States. Intelligent Fingerprinting System The system combines a disposable collection cartridge with a...

Recent company news

INBSIntelligent Bio Solutions2026-11-04 13:30 EST

Intelligent Bio Solutions to Present at the Webull Biotech Webinar on November 12

INBSIntelligent Bio Solutions2026-09-10 12:30 EST

Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET

INBSIntelligent Bio Solutions2026-09-09 12:30 EST

Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance

INBSIntelligent Bio Solutions2026-09-01 12:31 EST

Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission

INBSIntelligent Bio Solutions2026-09-01 12:30 EST

Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules

Stock data

Close
1.76 USD
Market cap
6.08M USD
Exchange
NASDAQ
Sector
MedTech
Location
United States